Correlation Between NYSE Composite and Seelos Therapeutics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Seelos Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Seelos Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Seelos Therapeutics, you can compare the effects of market volatilities on NYSE Composite and Seelos Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Seelos Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Seelos Therapeutics.
Diversification Opportunities for NYSE Composite and Seelos Therapeutics
-0.76 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and Seelos is -0.76. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Seelos Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seelos Therapeutics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Seelos Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seelos Therapeutics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Seelos Therapeutics go up and down completely randomly.
Pair Corralation between NYSE Composite and Seelos Therapeutics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 0.04 times more return on investment than Seelos Therapeutics. However, NYSE Composite is 26.95 times less risky than Seelos Therapeutics. It trades about 0.07 of its potential returns per unit of risk. Seelos Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 1,919,556 in NYSE Composite on September 18, 2024 and sell it today you would earn a total of 43,212 from holding NYSE Composite or generate 2.25% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 71.43% |
Values | Daily Returns |
NYSE Composite vs. Seelos Therapeutics
Performance |
Timeline |
NYSE Composite and Seelos Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Seelos Therapeutics
Pair trading matchups for Seelos Therapeutics
Pair Trading with NYSE Composite and Seelos Therapeutics
The main advantage of trading using opposite NYSE Composite and Seelos Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Seelos Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seelos Therapeutics will offset losses from the drop in Seelos Therapeutics' long position.NYSE Composite vs. Siriuspoint | NYSE Composite vs. Fomento Economico Mexicano | NYSE Composite vs. Boston Beer | NYSE Composite vs. Ambev SA ADR |
Seelos Therapeutics vs. ATAI Life Sciences | Seelos Therapeutics vs. Mind Medicine | Seelos Therapeutics vs. GH Research PLC | Seelos Therapeutics vs. Cybin Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |